FI119989B - Apilapeptididimeeri, menetelmä sen valmistamiseksi ja tällaisen dimeerin sisältävä farmaseuttinen koostumus sekä sen käyttö - Google Patents

Apilapeptididimeeri, menetelmä sen valmistamiseksi ja tällaisen dimeerin sisältävä farmaseuttinen koostumus sekä sen käyttö Download PDF

Info

Publication number
FI119989B
FI119989B FI970783A FI970783A FI119989B FI 119989 B FI119989 B FI 119989B FI 970783 A FI970783 A FI 970783A FI 970783 A FI970783 A FI 970783A FI 119989 B FI119989 B FI 119989B
Authority
FI
Finland
Prior art keywords
clover
peptide
dimer
monomer
peptide dimer
Prior art date
Application number
FI970783A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970783A (fi
FI970783A0 (fi
Inventor
Helle Fabricius Woeldike
Lars Thim
Per Franklin Nielsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI970783A publication Critical patent/FI970783A/fi
Publication of FI970783A0 publication Critical patent/FI970783A0/fi
Application granted granted Critical
Publication of FI119989B publication Critical patent/FI119989B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI970783A 1994-08-26 1997-02-25 Apilapeptididimeeri, menetelmä sen valmistamiseksi ja tällaisen dimeerin sisältävä farmaseuttinen koostumus sekä sen käyttö FI119989B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK98394 1994-08-26
DK98394 1994-08-26
DK9500343 1995-08-25
PCT/DK1995/000343 WO1996006861A1 (en) 1994-08-26 1995-08-25 Trefoil peptide dimer

Publications (3)

Publication Number Publication Date
FI970783A FI970783A (fi) 1997-02-25
FI970783A0 FI970783A0 (fi) 1997-02-25
FI119989B true FI119989B (fi) 2009-05-29

Family

ID=8099704

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970783A FI119989B (fi) 1994-08-26 1997-02-25 Apilapeptididimeeri, menetelmä sen valmistamiseksi ja tällaisen dimeerin sisältävä farmaseuttinen koostumus sekä sen käyttö

Country Status (21)

Country Link
EP (2) EP0777687B1 (ja)
JP (3) JPH10504720A (ja)
KR (1) KR100255911B1 (ja)
CN (1) CN1070867C (ja)
AT (1) ATE329929T1 (ja)
AU (1) AU694796B2 (ja)
BR (1) BR9508773A (ja)
CA (1) CA2196876C (ja)
CZ (2) CZ289705B6 (ja)
DE (1) DE69535060T2 (ja)
DK (1) DK0777687T3 (ja)
ES (1) ES2267104T3 (ja)
FI (1) FI119989B (ja)
HU (1) HU226921B1 (ja)
MX (1) MX9701239A (ja)
NO (1) NO323642B1 (ja)
PL (1) PL184516B1 (ja)
PT (1) PT777687E (ja)
RU (1) RU2162857C2 (ja)
UA (1) UA68324C2 (ja)
WO (1) WO1996006861A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063755A (en) 1991-02-14 2000-05-16 The General Hospital Corporation Intestinal trefoil proteins
US6221840B1 (en) 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
US6337195B1 (en) 1995-06-06 2002-01-08 Human Genome Sciences, Inc. Colon specific genes and proteins
US6525018B1 (en) 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US6426404B1 (en) 1997-08-25 2002-07-30 The General Hospital Corporation Receptor for intestinal trefoil factor
AU2001265239B2 (en) * 2000-05-26 2006-05-25 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1341817A2 (en) * 2000-12-08 2003-09-10 Novo Nordisk A/S Tff peptides
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
WO2002085402A1 (en) * 2001-04-24 2002-10-31 The General Hospital Corporation Methods and compositions for treating oral and eosophageal lesions
US20030186880A1 (en) * 2002-03-26 2003-10-02 Podolsky Daniel K. Combination therapy using trefoil peptides
EP1842858A3 (en) * 2001-04-24 2008-04-02 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
WO2002102403A1 (en) * 2001-06-14 2002-12-27 Novo Nordisk A/S Mucosal repair by tff dimer peptides
JP2005524641A (ja) * 2002-02-11 2005-08-18 ノボ　ノルディスク　アクティーゼルスカブ Ｔｆｆモノマーペプチドによる粘膜の粘性の管理
CA2552043A1 (en) 2004-01-21 2005-08-04 Novo Nordisk A/S Transglutaminase mediated conjugation of peptides
EP2575864A1 (en) 2010-06-04 2013-04-10 Trifoilium ApS Trefoil factors (tff) for the treatment of chronic pulmonary diseases
CN102526702A (zh) * 2010-12-23 2012-07-04 中国医学科学院基础医学研究所 小肽tff3治疗代谢综合征的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2104104A1 (en) * 1991-02-14 1992-09-03 Daniel K. Podolsky Intestinal trefoil proteins

Also Published As

Publication number Publication date
ES2267104T3 (es) 2007-03-01
NO323642B1 (no) 2007-06-18
HU226921B1 (en) 2010-03-01
CZ54897A3 (en) 1997-08-13
FI970783A (fi) 1997-02-25
DE69535060T2 (de) 2006-12-28
CN1156459A (zh) 1997-08-06
WO1996006861A1 (en) 1996-03-07
PL318785A1 (en) 1997-07-07
HUT77917A (hu) 1998-10-28
BR9508773A (pt) 1997-12-30
MX9701239A (es) 1997-05-31
DK0777687T3 (da) 2006-10-16
DE69535060D1 (de) 2006-07-27
JPH10504720A (ja) 1998-05-12
UA68324C2 (en) 2004-08-16
AU3341595A (en) 1996-03-22
EP1739091A1 (en) 2007-01-03
RU2162857C2 (ru) 2001-02-10
JP2007161720A (ja) 2007-06-28
CA2196876C (en) 2007-04-17
FI970783A0 (fi) 1997-02-25
EP0777687A1 (en) 1997-06-11
NO970844D0 (no) 1997-02-25
JP4156829B2 (ja) 2008-09-24
CZ289705B6 (cs) 2002-03-13
CA2196876A1 (en) 1996-03-07
NO970844L (no) 1997-04-28
CZ289864B6 (cs) 2002-04-17
KR100255911B1 (ko) 2000-05-01
PT777687E (pt) 2006-10-31
JP2002191385A (ja) 2002-07-09
EP0777687B1 (en) 2006-06-14
CN1070867C (zh) 2001-09-12
PL184516B1 (pl) 2002-11-29
ATE329929T1 (de) 2006-07-15
AU694796B2 (en) 1998-07-30

Similar Documents

Publication Publication Date Title
KR100611130B1 (ko) 식욕억제펩티드로이루어진약학적조성물의사용
FI119989B (fi) Apilapeptididimeeri, menetelmä sen valmistamiseksi ja tällaisen dimeerin sisältävä farmaseuttinen koostumus sekä sen käyttö
Thim et al. Characterization of human and rat intestinal trefoil factor produced in yeast
US5912229A (en) Use of a pharmaceutical composition comprising an appetite-suppressing peptide
US5783416A (en) Human spasmolytic polypeptide in glycosylated form
US20060293221A1 (en) Mucosal repair by TFF2 peptides
WO2002046226A2 (en) Trefoil factor 2 (tff2) peptides with moiety attached to asn15

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119989

Country of ref document: FI

MM Patent lapsed